M.A. Hallman

Fox Chase Cancer Center

Papers

1

Total Citations

28

H-Index

1

About

Dr. M.A. Hallman is a leading radiation oncologist whose research focuses on advancing stereotactic body radiation therapy (SBRT) for prostate cancer, with a particular emphasis on comparing treatment delivery technologies. In their highly cited 2016 study, Hallman conducted a rigorous comparison of robotic arm versus gantry linear accelerator SBRT, providing critical insights into the efficacy and practical considerations of these competing platforms. This work, which has garnered 28 citations, helped clarify the relative advantages of each system in terms of treatment precision, delivery time, and patient outcomes. Hallman’s contributions are especially significant given the rising popularity of SBRT—a technique delivering high-dose radiation in fewer fractions—as a convenient and effective alternative to conventional radiotherapy for prostate cancer. By systematically evaluating these technologies, Hallman has equipped clinicians with evidence-based guidance for selecting optimal treatment approaches, ultimately improving patient care. Their research underscores a commitment to refining cancer therapy through comparative effectiveness studies, making them a valuable voice in the evolving landscape of radiation oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
28
Total Citations
28
Avg Citations/Paper
🏆 Most Cited Paper
A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer
28 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Fox Chase Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago